ERBB2 and metastatic malignant neoplasm in the lymph nodes: Subsequently, these factors underwent multifactorial logistic regression analysis, ultimately revealing 6 independent risk factors: the number of lymph node metastases, ER expression, HER-2 expression, molecular typing, clinical staging, and ultrasonographic blood flow grading (refer to Table 3).